Use of vitamin D analogs to treat conditions related to increased oxidative stress

摘要

A pharmaceutical composition for reducing the rate at which skin ages or for treating cancer, acne or rosacea. The composition comprises a pharmaceutically acceptable excipient in combination with 26,27-hexafluoro-1,25-dihydroxy vitamin D3. The composition is preferably administered topically at a concentration of about 0.0001% weight to about 0.01% weight.